Compare LITB & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITB | ABVC |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.8M | 50.5M |
| IPO Year | N/A | N/A |
| Metric | LITB | ABVC |
|---|---|---|
| Price | $2.87 | $1.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.1K | ★ 52.9K |
| Earning Date | 11-12-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $219,105,000.00 | $797,916.00 |
| Revenue This Year | N/A | $735.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.54 | ★ N/A |
| Revenue Growth | N/A | ★ 56.52 |
| 52 Week Low | $0.91 | $0.40 |
| 52 Week High | $4.17 | $5.48 |
| Indicator | LITB | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 60.98 | 34.23 |
| Support Level | $2.50 | $2.00 |
| Resistance Level | $2.69 | $2.10 |
| Average True Range (ATR) | 0.23 | 0.11 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 76.00 | 5.88 |
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.